Suraksha Health Village, 121, SBH complex, Gurunanak Nagar Road, Vijayawada, Andhra Pradesh, India.
Laila Nutraceuticals R&D Center, 181/2, JRD Tata Industrial Estate, Kanur, Vijayawada, Andhra Pradesh, 520007, India.
J Int Soc Sports Nutr. 2018 Oct 22;15(1):50. doi: 10.1186/s12970-018-0257-4.
A proprietary composition GMCT contains extracts of two popular Asian herbs viz., Garcinia mangostana (GM) fruit rind and Cinnamomum tamala (CT) leaf. We systematically evaluated physical performance and muscle strength enhancing ability of GMCT in a preclinical mouse model followed by a 42-days double-blind placebo controlled human trial in resistance trained adult males.
Four groups of Swiss albino mice (20-30 g body weight) (n = 6) were fed a standard laboratory diet and given Carboxymethylcellulose sodium (CMC), 150 mg/kg GMCT (GMCT-150), 300 mg/kg GMCT (GMCT-300) or 50 mg/kg Oxymetholone (OXY) via oral gavage for 21 days. On day 22, the animals' physical performance and muscle strength were assessed in a forced swimming test (FST) and forelimb grip strength experiment, respectively. In the human trial, thirty-eight resistance-trained young adults (mean age 26.32 ± 4.39 years, body weight 67.79 ± 12.84 kg, BMI 22.92 ± 3.54 kg/m) completed the trial. The participants received either GMCT (n = 19; 800 mg daily) or matched placebo (n = 19) for 42 days. As primary variables, 1-RM bench press, 1-RM leg press, and leg extension repetitions were measured at baseline and on days 14, 28 and 42 of the intervention. Anthropometric parameters and serum markers such as free testosterone, insulin-like growth factor 1 (IGF-1), insulin and lactate were also measured before and after the intervention.
GMCT-300 mice showed significant improvement in swimming time (GMCT: 395.3 ± 81.70 s vs. CMC: 271.6 ± 56.86 s; p = 0.0166), distance (GMCT: 341.22 ± 65.88 m vs. CMC: 260.84 ± 49.15 m; p = 0.0461) and grip strength (GMCT: 43.92 ± 6.97 N vs. CMC: 35.0 ± 6.92 N; p = 0.0490), compared with the CMC group. At the end of the 42-day human trial, the per protocol analyses reveal that mean changes from baseline 1-RM bench press (GMCT: 23.47 ± 10.07 kg vs. PL: 3.42 ± 2.06 kg; p < 0.0001), leg press (GMCT: 29.32 ± 16.17 kg vs. PL: 5.21 ± 1.72 kg; p < 0.0001), number of leg extension repetitions (GMCT: 6.58 ± 2.57 vs. PL: 2.05 ± 1.22; p < 0.0001) in GMCT group were significantly improved, compared with placebo. Intergroup difference analyses show that the changes from baseline left arm (GMCT: 1.09 ± 0.36 cm vs. PL: 0.68 ± 0.42 cm; p = 0.0023), right arm (GMCT: 1.50 ± 0.44 cm vs. PL: 1.11 ± 0.43 cm; p = 0.0088) circumference and lean mass (GMCT: 2.29 ± 2.09 kg vs. PL: 0.52 ± 2.58 kg; p = 0.0404) in GMCT group were also significantly improved, compared with placebo. In comparison to placebo, GMCT supplementation did not improve free testosterone, IGF-1, insulin or lactate levels. Parameters of clinical biochemistry, hematology, urine and vital signs of the participants were within the normal range.
GMCT supplementation is effective in increasing muscle strength, muscle size and, total lean mass, as well as endurance performance.
Clinical Trial Registry of India (CTRI/2015/01/005374), Registered on Jan 07, 2015; CTRI Website URL - http://ctri.nic.in.
一种专有的组合物 GMCT 包含两种流行的亚洲草药的提取物,即藤黄果(GM)果皮和樟科(CT)叶。我们系统地评估了 GMCT 在临床前小鼠模型中的体能和肌肉力量增强能力,随后在 38 名经过阻力训练的成年男性中进行了为期 42 天的双盲安慰剂对照人体试验。
4 组瑞士白化小鼠(体重 20-30 克)(每组 6 只)喂食标准实验室饮食,并经口灌胃给予羧甲基纤维素钠(CMC)、150mg/kg GMCT(GMCT-150)、300mg/kg GMCT(GMCT-300)或 50mg/kg 氧雄龙(OXY),连续 21 天。第 22 天,在强迫游泳试验(FST)中评估动物的体能,在握力试验中评估肌肉力量。在人体试验中,38 名经过阻力训练的年轻人(平均年龄 26.32±4.39 岁,体重 67.79±12.84 公斤,BMI 22.92±3.54 公斤/米)完成了试验。参与者接受 GMCT(n=19;每天 800mg)或匹配的安慰剂(n=19)治疗 42 天。主要变量为:1-RM 卧推、1-RM 腿举和腿屈伸重复次数,分别在干预前和干预第 14、28 和 42 天测量。干预前后还测量了人体测量参数和血清标志物,如游离睾酮、胰岛素样生长因子 1(IGF-1)、胰岛素和乳酸。
GMCT-300 组小鼠的游泳时间(GMCT:395.3±81.70 秒 vs. CMC:271.6±56.86 秒;p=0.0166)、距离(GMCT:341.22±65.88 米 vs. CMC:260.84±49.15 米;p=0.0461)和握力(GMCT:43.92±6.97N vs. CMC:35.0±6.92N;p=0.0490)均显著提高,与 CMC 组相比。在为期 42 天的人体试验结束时,按方案分析显示,1-RM 卧推的平均变化(GMCT:23.47±10.07kg vs. PL:3.42±2.06kg;p<0.0001)、腿举(GMCT:29.32±16.17kg vs. PL:5.21±1.72kg;p<0.0001)和腿屈伸重复次数(GMCT:6.58±2.57 次 vs. PL:2.05±1.22 次;p<0.0001)在 GMCT 组均有显著改善,与安慰剂组相比。组间差异分析显示,GMCT 组左手臂(GMCT:1.09±0.36cm vs. PL:0.68±0.42cm;p=0.0023)、右手臂(GMCT:1.50±0.44cm vs. PL:1.11±0.43cm;p=0.0088)周长和瘦体重(GMCT:2.29±2.09kg vs. PL:0.52±2.58kg;p=0.0404)也显著改善,与安慰剂组相比。与安慰剂相比,GMCT 补充剂并未改善游离睾酮、IGF-1、胰岛素或乳酸水平。参与者的临床生化、血液学、尿液和生命体征参数均在正常范围内。
GMCT 补充剂可有效提高肌肉力量、肌肉大小和总瘦体重,以及耐力表现。
印度临床试验注册中心(CTRI/2015/01/005374),注册于 2015 年 1 月 7 日;CTRI 网站地址 - http://ctri.nic.in。